Description

NSE admits commercial paper securities of Biocon Limited and Kotak Securities Limited to trading on the debt market segment effective January 05, 2026.

Summary

NSE has admitted privately placed commercial paper securities to trading on its debt market segment effective January 05, 2026. The circular covers one fresh issue by Biocon Limited and two re-issues by Kotak Securities Limited, all with face value of ₹5,00,000 per security and maturity periods ranging from 2 to 3 months.

Key Points

  • Biocon Limited: Fresh issue of 4,000 commercial papers (ISIN: INE376G14057) allotted on January 02, 2026, maturing March 03, 2026, issued at ₹4,94,472.50
  • Kotak Securities Limited (Series 240): Re-issue of 7,000 commercial papers (ISIN: INE028E14UF5) allotted on January 02, 2026, maturing March 24, 2026, issued at ₹4,92,998
  • Kotak Securities Limited (Series 242): Re-issue of 1,000 commercial papers (ISIN: INE028E14UG3) allotted on January 02, 2026, maturing March 25, 2026, issued at ₹4,92,913
  • All securities have face value of ₹5,00,000 per unit
  • Listing pursuant to Regulation 3.1.1 of NSE Debt Market (Trading) Regulations

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification under existing NSE Debt Market Trading Regulations.

Compliance Requirements

  • Exchange members are notified of the new securities admitted to trading
  • Securities can be traded on the debt market segment using the designated security codes from January 05, 2026
  • Trading participants should update their systems with the ISIN codes and security details provided

Important Dates

  • Allotment Date: January 02, 2026 (all securities)
  • Listing Date: January 05, 2026 (effective date for trading)
  • Redemption Dates:
    • Biocon CP: March 03, 2026
    • Kotak Securities CP (Series 240): March 24, 2026
    • Kotak Securities CP (Series 242): March 25, 2026

Impact Assessment

This is a routine administrative circular with minimal market impact. It provides liquidity options for short-term debt instruments on the exchange. The commercial paper issuances represent standard working capital management tools for the issuers. Market participants holding or trading these securities now have exchange-based trading facility. No impact on equity markets or broader regulatory framework.

Impact Justification

Routine listing notification for commercial paper securities with no broader market implications or regulatory changes